Adagio Medical posts $17.8M Q3 profit on notes gain
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Adagio Medical Holdings, Inc. (ADGM) reported third-quarter 2026 net income of $17.8 million, compared with a $10.1 million net loss a year earlier. The result was primarily driven by a $23.0 million noncash gain from the fair-value change in its 13% Senior Secured Convertible Notes; diluted net loss per share was $(5.13). Revenue was zero in both periods, and operating expenses were $4.4 million, compared with $5.7 million.
Cash and cash equivalents were $3.1 million as of September 30, 2026, compared with $17.1 million as of December 31, 2025. Adagio effected a 1-for-30 reverse stock split on November 6, with split-adjusted trading beginning November 9. Its vCLAS PMA application remains under FDA review, the vCLAS Ultra IDE study has begun, and the Board’s strategic-alternatives review continues.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Major pointNet income was $17.8 million, primarily due to a noncash notes gain.
Negative
- None.
Filing Explained
The completed 1-for-30 reverse split consolidated existing common shares while leaving the authorized share count and par value unchanged; Adagio said it was undertaken in connection with efforts to regain Nasdaq’s minimum-bid-price compliance.
8-K Event Classification
Key Figures
Key Terms
13% Senior Secured Convertible Notes financial
fair value adjustment financial
Premarket Approval (PMA) regulatory
Investigational Device Exemption (IDE) regulatory
anti-dilutive financial
reverse stock split financial
Stock Split
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What drove ADGM’s third-quarter 2026 net income?
Where is Adagio’s vCLAS system commercially available?
AI-generated analysis. How Rhea-AI works. Not financial advice.